1. Home
  2. RENE vs ZYXI Comparison

RENE vs ZYXI Comparison

Compare RENE & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RENE
  • ZYXI
  • Stock Information
  • Founded
  • RENE 2021
  • ZYXI 1996
  • Country
  • RENE United States
  • ZYXI United States
  • Employees
  • RENE N/A
  • ZYXI N/A
  • Industry
  • RENE Blank Checks
  • ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • RENE Finance
  • ZYXI Health Care
  • Exchange
  • RENE Nasdaq
  • ZYXI Nasdaq
  • Market Cap
  • RENE 243.8M
  • ZYXI 257.1M
  • IPO Year
  • RENE 2022
  • ZYXI N/A
  • Fundamental
  • Price
  • RENE $11.48
  • ZYXI $7.71
  • Analyst Decision
  • RENE
  • ZYXI Strong Buy
  • Analyst Count
  • RENE 0
  • ZYXI 2
  • Target Price
  • RENE N/A
  • ZYXI $13.50
  • AVG Volume (30 Days)
  • RENE 55.8K
  • ZYXI 98.5K
  • Earning Date
  • RENE 01-01-0001
  • ZYXI 10-24-2024
  • Dividend Yield
  • RENE N/A
  • ZYXI N/A
  • EPS Growth
  • RENE N/A
  • ZYXI N/A
  • EPS
  • RENE 0.36
  • ZYXI 0.18
  • Revenue
  • RENE N/A
  • ZYXI $193,614,000.00
  • Revenue This Year
  • RENE N/A
  • ZYXI $11.68
  • Revenue Next Year
  • RENE N/A
  • ZYXI $20.90
  • P/E Ratio
  • RENE $32.04
  • ZYXI $42.70
  • Revenue Growth
  • RENE N/A
  • ZYXI 9.11
  • 52 Week Low
  • RENE $10.81
  • ZYXI $7.04
  • 52 Week High
  • RENE $11.58
  • ZYXI $13.77
  • Technical
  • Relative Strength Index (RSI)
  • RENE 81.27
  • ZYXI 42.26
  • Support Level
  • RENE $11.40
  • ZYXI $7.61
  • Resistance Level
  • RENE $11.49
  • ZYXI $7.99
  • Average True Range (ATR)
  • RENE 0.01
  • ZYXI 0.28
  • MACD
  • RENE -0.00
  • ZYXI -0.03
  • Stochastic Oscillator
  • RENE 80.00
  • ZYXI 11.63

About RENE Cartesian Growth Corporation II

Cartesian Growth Corp II is a blank check company.

About ZYXI Zynex Inc.

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

Share on Social Networks: